Cargando…

Phase 2 trial of neoadjuvant docetaxel, oxaliplatin, and S‐1 for clinical stage III gastric or esophagogastric junction adenocarcinoma

BACKGROUND: Although perioperative treatment has been the standard of care for resectable gastric cancer in the West, postoperative adjuvant chemotherapy is still the standard in Japan. We conducted the first phase 2 trial to investigate the efficacy and safety of neoadjuvant docetaxel, oxaliplatin,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kurokawa, Yukinori, Kawase, Tomono, Takeno, Atsushi, Furukawa, Haruna, Yoshioka, Ryo, Saito, Takuro, Takahashi, Tsuyoshi, Shimokawa, Toshio, Eguchi, Hidetoshi, Doki, Yuichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043771/ https://www.ncbi.nlm.nih.gov/pubmed/36998295 http://dx.doi.org/10.1002/ags3.12632

Ejemplares similares

Essential updates 2021/2022: Perioperative and surgical treatments for gastric and esophagogastric junction cancer
por: Yanagimoto, Yoshitomo, et al.
Publicado: (2023)

Neoadjuvant docetaxel, oxaliplatin and S-1 therapy for the patients with large type 3 or type 4 gastric cancer (OGSG1902): protocol of a multi-center, phase II study
por: Endo, Shunji, et al.
Publicado: (2022)

Neutrophil-to-lymphocyte ratio after neoadjuvant chemotherapy as an independent prognostic factor in patients with esophageal squamous cell carcinoma
por: Yamada, Moyuru, et al.
Publicado: (2022)

Pathological Regression of Lymph Nodes Better Predicts Long-term Survival in Esophageal Cancer Patients Undergoing Neoadjuvant Chemotherapy Followed by Surgery
por: Hagi, Takaomi, et al.
Publicado: (2022)

Prediction of esophagogastric varices associated with oxaliplatin administration
por: Satta, Yosuke, et al.
Publicado: (2021)

Heparinized swine models for better surgical/endoscopic training
por: Kubo, Yuto, et al.
Publicado: (2021)

Long-term response to pimitespib in postoperative recurrent gastrointestinal stromal tumors with PDGFRA D842V mutation: a case report
por: Teranishi, Ryugo, et al.
Publicado: (2023)

Is simply covering the patient's mouth with a surgical mask during transnasal endoscopy sufficient as an anti-COVID-19 measure?
por: Nose, Yohei, et al.
Publicado: (2023)

Anti-metastatic effect of methylprednisolone targeting vascular endothelial cells under surgical stress
por: Hagi, Takaomi, et al.
Publicado: (2021)

Gas leakages from gastrointestinal endoscopy system—its visualization and semi-quantification utilizing schlieren optical system in the swine models
por: Ishida, Tomo, et al.
Publicado: (2022)

Clinical Significance of Intramural Metastasis as an Independent Prognostic Factor in Esophageal Squamous Cell Carcinoma
por: Ushimaru, Yuki, et al.
Publicado: (2023)

A case of Barrett’s esophageal adenocarcinoma and severe scoliosis with successful salvage esophagectomy after definitive chemoradiotherapy
por: Taguchi, Daisuke, et al.
Publicado: (2023)

Surgical Treatment of Gastroesophageal Junction Cancer
por: Hashimoto, Tadayoshi, et al.
Publicado: (2018)

A phase II study of neoadjuvant capecitabine, oxaliplatin, and irinotecan (XELOXIRI) in patients with locally advanced rectal cancer
por: Matsuda, Chu, et al.
Publicado: (2022)

NOTCH3 limits the epithelial–mesenchymal transition and predicts a favorable clinical outcome in esophageal cancer
por: Matsuura, Norihiro, et al.
Publicado: (2021)

Risk stratification of oesophageal squamous cell carcinoma using change in total lesion glycolysis and number of PET-positive lymph nodes
por: Nose, Yohei, et al.
Publicado: (2023)

Association between circ_0004365 and cisplatin resistance in esophageal squamous cell carcinoma
por: Yamada, Moyuru, et al.
Publicado: (2023)

Postoperative pregnancy in female achalasia patients: Report of three cases
por: Kubo, Yuto, et al.
Publicado: (2021)

PRIMA‐1 induces p53‐mediated apoptosis by upregulating Noxa in esophageal squamous cell carcinoma with TP53 missense mutation
por: Furukawa, Haruna, et al.
Publicado: (2017)

The Impact of Perioperative Fluid Balance on Postoperative Complications after Esophagectomy for Esophageal Cancer
por: Kubo, Yuto, et al.
Publicado: (2022)

Utility of monthly minodronate for osteoporosis after gastrectomy: Prospective multicenter randomized controlled trials
por: Hirota, Masashi, et al.
Publicado: (2021)

Protocol of OGSG 1901: a phase II trial of ramucirumab plus irinotecan for patients with early relapsed gastric cancer during or after adjuvant docetaxel plus S − 1 therapy
por: Yamaguchi, Toshifumi, et al.
Publicado: (2022)

A novel, simple, and dedicated device for endoscopic mucosal defect closure
por: Nose, Yohei, et al.
Publicado: (2022)

Feasibility of perioperative chemotherapy with infusional 5-FU, leucovorin, and oxaliplatin with (FLOT) or without (FLO) docetaxel in elderly patients with locally advanced esophagogastric cancer
por: Lorenzen, S, et al.
Publicado: (2013)

Endoscopic application of novel, infection‐free, advanced hemostatic material: Its usefulness to upper gastrointestinal oozing
por: Kubo, Yuto, et al.
Publicado: (2021)

Robotic Distal Gastrectomy Reduces Drain Amylase Values in Patients With a Small Pancreas-left Gastric Artery Angle
por: Teranishi, Ryugo, et al.
Publicado: (2022)

Low mitochondrial DNA copy number induces chemotherapy resistance via epithelial-mesenchymal transition by DNA methylation in esophageal squamous cancer cells
por: Kubo, Yuto, et al.
Publicado: (2022)

Development of a new gastrointestinal endoscope forceps plug that can minimize gas leakage
por: Ishida, Tomo, et al.
Publicado: (2023)

Irinotecan, docetaxel and oxaliplatin combination in metastatic gastric or gastroesophageal junction adenocarcinoma
por: Di Lauro, L, et al.
Publicado: (2007)

Perioperative chemotherapy with 5-FU, leucovorin, oxaliplatin, and docetaxel (FLOT) for esophagogastric adenocarcinoma: ten years real-life experience from a surgical perspective
por: Sisic, Leila, et al.
Publicado: (2023)

Locally advanced rectal cancer receiving total neoadjuvant therapy combined with nivolumab: a case report and literature review
por: Mori, Ryota, et al.
Publicado: (2022)

Surgery for multiple gastric gastrointestinal stromal tumors and large esophageal diverticulum related to germline mutation of the KIT gene: a case report
por: Arita, Asami, et al.
Publicado: (2023)

Multicentre biomarker cohort study on the efficacy of nivolumab treatment for gastric cancer
por: Hagi, Takaomi, et al.
Publicado: (2020)

Comparison of 5‐year postoperative outcomes after Billroth I and Roux‐en‐Y reconstruction following distal gastrectomy for gastric cancer: Results from a multi‐institutional randomized controlled trial
por: Kimura, Yutaka, et al.
Publicado: (2020)

Effects of an oral elemental nutritional supplement in gastric cancer patients with adjuvant S‐1 chemotherapy after gastrectomy: A multicenter, open‐label, single‐arm, prospective phase II study (OGSG1108)
por: Imamura, Hiroshi, et al.
Publicado: (2021)

Immunoscore Signatures in Surgical Specimens and Tumor-Infiltrating Lymphocytes in Pretreatment Biopsy Predict Treatment Efficacy and Survival in Esophageal Cancer
por: Noma, Toshiki, et al.
Publicado: (2023)

Prospective, open, multi-centre phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and oxaliplatin in patients with adenocarcinoma of the oesophagogastric junction
por: Moehler, Markus, et al.
Publicado: (2013)

Can proximal Gastrectomy Be Justified for Advanced Adenocarcinoma of the Esophagogastric Junction?
por: Sato, Yuya, et al.
Publicado: (2018)

Impacts of neoadjuvant therapy on the number of dissected lymph nodes in esophagogastric junction cancer patients
por: Wang, Qi, et al.
Publicado: (2023)

Perioperative Safety and Effectiveness of Neoadjuvant Therapy with Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel Plus Apatinib in Locally Advanced Gastric Cancer
por: Zhang, Yonglei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_70tau7e5kqp3bikdr6srkt25up